Recent Researchs Reveal That HPV Vaccine Is Proven To Be Able To Reduce The Risk Of Cervical Cancer By 80 Percent

Illustration of the HPV (Pexels/Frank Merino) vaccine

JAKARTA - Recent research published in the US Centers for Disease Control and Prevention (CDC) revealed the benefits of human papillomavirus (HPV) vaccines in cervical cancer. HPV is the most common sexually transmitted infection, which can cause cervical cancer, vaginal cancer, vulva cancer, and others.

Through the CDC findings, it was revealed that the HPV vaccine could reduce the cervical precancer lesion rate by about 80 percent. This result was obtained after research was conducted on women aged 20-24 years, who were discrinated for cervical cancer between 2008 and 2022.

The data is consistent with the considerable impact of the US HPV vaccination program on the cervical precancer, with the largest decline in the youngest age group whose vaccination benefits will be first observed, the researchers said in a statement, quoted from Forbes, on Monday, March 3, 2025.

An expert, Jane Montealegre from the MD Anderseon Cancer Center in Houston, assessed that the CDC's research findings were very good for the use of the HPV vaccine in the future. With these findings, it is hoped that more young parents and women will use the HPV vaccine.

"This should convince parents that they are doing the right thing in vaccinating their children against HPV," he said.

As is known, young women are a group of people who are strongly recommended to receive the HPV vaccine. This vaccine has been recommended in the United States since 2006, for girls aged 11 or 12 years.

Then the recommendation for the use of this vaccine continues for boys of the same age from 2011. Subsequent vaccine injections are recommended for anyone up to 26 years old.

Meanwhile, the HPV vaccine is an important part of the World Health Organization (WHO)'s goal to eliminate cervical cancer globally in the future. Several countries have provided large-scale vaccinations and screening to prevent the development of cervical cancer more quickly.